Evaluation of health system readiness and coverage of intermittent preventive treatment of malaria in infants (IPTi) in Kambia district to inform national scale-up in Sierra Leone
Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts,...
Saved in:
Published in | Malaria journal Vol. 20; no. 1; p. 74 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
06.02.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services.
This mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15-17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3-15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation.
Most HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2-7%]; 11% post-IPTi [95%CI 8-15%], p < 0.01). From the household survey, 299/459 (67.4%) children ≥ 10 weeks old received the first dose of IPTi (versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children ≥ 14 weeks old received the second IPTi dose (versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children ≥ 9 months old received the third IPTi dose (versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation.
Kambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. |
---|---|
AbstractList | Background Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services. Methods This mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15-17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3-15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation. Results Most HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2-7%]; 11% post-IPTi [95%CI 8-15%], p < 0.01). From the household survey, 299/459 (67.4%) children [greater than or equai to] 10 weeks old received the first dose of IPTi (versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children [greater than or equai to] 14 weeks old received the second IPTi dose (versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children [greater than or equai to] 9 months old received the third IPTi dose (versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation. Conclusions Kambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. Keywords: Malaria, Sierra Leone, Infants, IPTi, Evaluation, Coverage, Household survey, National scale-up Abstract Background Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services. Methods This mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15–17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3–15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation. Results Most HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2–7%]; 11% post-IPTi [95%CI 8–15%], p < 0.01). From the household survey, 299/459 (67.4%) children ≥ 10 weeks old received the first dose of IPTi (versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children ≥ 14 weeks old received the second IPTi dose (versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children ≥ 9 months old received the third IPTi dose (versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation. Conclusions Kambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. Abstract Background Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services. Methods This mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15–17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3–15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation. Results Most HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2–7%]; 11% post-IPTi [95%CI 8–15%], p < 0.01). From the household survey, 299/459 (67.4%) children ≥ 10 weeks old received the first dose of IPTi ( versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children ≥ 14 weeks old received the second IPTi dose ( versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children ≥ 9 months old received the third IPTi dose ( versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation. Conclusions Kambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services. This mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15-17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3-15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation. Most HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2-7%]; 11% post-IPTi [95%CI 8-15%], p < 0.01). From the household survey, 299/459 (67.4%) children ≥ 10 weeks old received the first dose of IPTi (versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children ≥ 14 weeks old received the second IPTi dose (versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children ≥ 9 months old received the third IPTi dose (versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation. Kambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. Background Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services. Methods This mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15–17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3–15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation. Results Most HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2–7%]; 11% post-IPTi [95%CI 8–15%], p < 0.01). From the household survey, 299/459 (67.4%) children ≥ 10 weeks old received the first dose of IPTi (versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children ≥ 14 weeks old received the second IPTi dose (versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children ≥ 9 months old received the third IPTi dose (versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation. Conclusions Kambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. BACKGROUNDIntermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services. METHODSThis mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15-17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3-15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation. RESULTSMost HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2-7%]; 11% post-IPTi [95%CI 8-15%], p < 0.01). From the household survey, 299/459 (67.4%) children ≥ 10 weeks old received the first dose of IPTi (versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children ≥ 14 weeks old received the second IPTi dose (versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children ≥ 9 months old received the third IPTi dose (versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation. CONCLUSIONSKambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria. Sierra Leone is the first country to implement IPTi nationwide. IPTi implementation was evaluated in Kambia, one of two initial pilot districts, to assess quality and coverage of IPTi services. This mixed-methods evaluation had two phases, conducted 3 (phase 1) and 15-17 months (phase 2) after IPTi implementation. Methods included: assessments of 18 health facilities (HF), including register data abstraction (phases 1 and 2); a knowledge, attitudes and practices survey with 20 health workers (HWs) in phase 1; second-generation sequencing of SP resistance markers (pre-IPTi and phase 2); and a cluster-sample household survey among caregivers of children aged 3-15 months (phase 2). IPTi and vaccination coverage from the household survey were calculated from child health cards and maternal recall and weighted for the complex sampling design. Interrupted time series analysis using a Poisson regression model was used to assess changes in malaria cases at HF before and after IPTi implementation. Most HWs (19/20) interviewed had been trained on IPTi; 16/19 reported feeling well prepared to administer it. Nearly all HFs (17/18 in phase 1; 18/18 in phase 2) had SP for IPTi in stock. The proportion of parasite alleles with dhps K540E mutations increased but remained below the 50% WHO-recommended threshold for IPTi (4.1% pre-IPTi [95%CI 2-7%]; 11% post-IPTi [95%CI 8-15%], p < 0.01). From the household survey, 299/459 (67.4%) children [greater than or equai to] 10 weeks old received the first dose of IPTi (versus 80.4% for second pentavalent vaccine, given simultaneously); 274/444 (62.5%) children [greater than or equai to] 14 weeks old received the second IPTi dose (versus 65.4% for third pentavalent vaccine); and 83/217 (36.4%) children [greater than or equai to] 9 months old received the third IPTi dose (versus 52.2% for first measles vaccine dose). HF register data indicated no change in confirmed malaria cases among infants after IPTi implementation. Kambia district was able to scale up IPTi swiftly and provide necessary health systems support. The gaps between IPTi and childhood vaccine coverage need to be further investigated and addressed to optimize the success of the national IPTi programme. |
ArticleNumber | 74 |
Audience | Academic |
Author | Gleason, Brigette Eleeza, Oliver Mansaray, Anthony Toure, Mame Steinhardt, Laura Kassa, Getachew Lahuerta, Maria Sutton, Roberta Smith, Samuel Juana Rabkin, Miriam Akinjeji, Adewale Jalloh, Mohamed F Meshnick, Steven R Deutsch-Feldman, Molly Friedman, Michael Parmley, Lauren |
Author_xml | – sequence: 1 givenname: Maria orcidid: 0000-0002-9748-9273 surname: Lahuerta fullname: Lahuerta, Maria email: ml2842@cumc.columbia.edu, ml2842@cumc.columbia.edu organization: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA. ml2842@cumc.columbia.edu – sequence: 2 givenname: Roberta surname: Sutton fullname: Sutton, Roberta organization: ICAP at Columbia University, Mailman School of Public Health, New York, USA – sequence: 3 givenname: Anthony surname: Mansaray fullname: Mansaray, Anthony organization: ICAP at Columbia University, Freetown, Sierra Leone – sequence: 4 givenname: Oliver surname: Eleeza fullname: Eleeza, Oliver organization: ICAP at Columbia University, Freetown, Sierra Leone – sequence: 5 givenname: Brigette surname: Gleason fullname: Gleason, Brigette organization: United States Centers for Disease Control and Prevention, Freetown, Sierra Leone – sequence: 6 givenname: Adewale surname: Akinjeji fullname: Akinjeji, Adewale organization: ICAP at Columbia University, Freetown, Sierra Leone – sequence: 7 givenname: Mohamed F surname: Jalloh fullname: Jalloh, Mohamed F organization: Immunization Systems Branch, Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, USA – sequence: 8 givenname: Mame surname: Toure fullname: Toure, Mame organization: ICAP at Columbia University, Freetown, Sierra Leone – sequence: 9 givenname: Getachew surname: Kassa fullname: Kassa, Getachew organization: ICAP at Columbia University, Mailman School of Public Health, New York, USA – sequence: 10 givenname: Steven R surname: Meshnick fullname: Meshnick, Steven R organization: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA – sequence: 11 givenname: Molly surname: Deutsch-Feldman fullname: Deutsch-Feldman, Molly organization: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA – sequence: 12 givenname: Lauren surname: Parmley fullname: Parmley, Lauren organization: ICAP at Columbia University, Mailman School of Public Health, New York, USA – sequence: 13 givenname: Michael surname: Friedman fullname: Friedman, Michael organization: United States Centers for Disease Control and Prevention, Freetown, Sierra Leone – sequence: 14 givenname: Samuel Juana surname: Smith fullname: Smith, Samuel Juana organization: National Malaria Control Program, Ministry of Health and Sanitation, Freetown, Sierra Leone – sequence: 15 givenname: Miriam surname: Rabkin fullname: Rabkin, Miriam organization: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, USA – sequence: 16 givenname: Laura surname: Steinhardt fullname: Steinhardt, Laura organization: Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33549098$$D View this record in MEDLINE/PubMed |
BookMark | eNptkt1u1DAQhSNURH_gBbhAlrgpFylx7NjODVJVFahYCSTKtTV2JrteJfFie1fqc_GCON1Sugglkq2Zb06c43NaHE1-wqJ4TasLSpV4H2ndMlFWNS0rJmhTsmfFCeWyKWslm6Mn--PiNMZ1VVGpZP2iOGas4W3VqpPi1_UOhi0k5yfie7JCGNKKxLuYcCQBoXMTxkhg6oj1OwywxJlzU8IwupRwSmQTcJdXt0OS8kga52KGRhggOMhwfnuYUiTnN99u3bu58gVGk3udiyk4m0jyM-TDSKb708BAooUBy-1mxr87DAHIArMFL4vnPQwRXz2sZ8WPj9e3V5_LxddPN1eXi9I2gqVS1Sh5b7ACq9DSvlHc8Jpb7IGjMj3mDprOUgZSgrAGDDBjbbaGq76S7Ky42et2HtZ6E9wI4U57cPq-4MNSQ0jODqhbZbjkFavbvuZ91YBp8o5VRghqOMWs9WGvtdmaETubLQowHIgedia30ku_01IJIYXKAucPAsH_3GJMenTR4jDAhH4bdc2V5HUrJc3o23_Qtd-G7OhM5WunNW3YX2qZXdaz9_m7dhbVl6JhopVcikxd_IfKT4ejs_kyepfrBwP1fsAGH2PA_vEfaaXn2Op9bHWOrb6PrZ7P8uapO48jf3LKfgOFXO2w |
CitedBy_id | crossref_primary_10_1016_j_ssmhs_2024_100012 crossref_primary_10_1186_s12936_023_04564_9 crossref_primary_10_1371_journal_pcbi_1010317 crossref_primary_10_1186_s12936_023_04575_6 crossref_primary_10_1186_s12936_023_04793_y crossref_primary_10_1186_s12936_024_04977_0 crossref_primary_10_1186_s12889_023_17534_2 |
Cites_doi | 10.1186/s12879-019-4523-0 10.1016/S0035-9203(01)90250-0 10.1086/505431 10.1186/1475-2875-8-191 10.1073/pnas.85.23.9109 10.1093/infdis/jiy223 10.1016/j.vaccine.2020.07.031 10.1016/0166-6851(89)90173-4 10.1101/656561 10.1086/338566 10.1214/aos/1176350273 10.4269/ajtmh.1995.52.565 10.1086/518575 10.1186/s12936-017-1886-9 10.1016/S0140-6736(03)13504-0 10.1046/j.1365-2958.1997.2821646.x 10.1111/j.1365-3156.2006.01725.x 10.1016/S0140-6736(09)61258-7 10.1128/AAC.00513-07 10.1186/1475-2875-9-369 10.1002/14651858.CD011525.pub2 10.1086/522160 10.1016/S0140-6736(00)04643-2 10.1136/bmj.331.7519.727 10.1016/S2214-109X(17)30152-3 10.1111/tmi.12595 10.7189/jogh.10.010420 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | NPM AAYXX CITATION 3V. 7SS 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO F1W FYUFA GHDGH H94 H95 H97 K9. L.G M0S M1P M7N PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12936-021-03615-3 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Entomology Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central ASFA: Aquatic Sciences and Fisheries Abstracts Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality ProQuest Health & Medical Complete (Alumni) Aquatic Science & Fisheries Abstracts (ASFA) Professional Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Entomology Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ASFA: Aquatic Sciences and Fisheries Abstracts ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1475-2875 |
EndPage | 74 |
ExternalDocumentID | oai_doaj_org_article_98b4740329f24f05ab59f230b661b41e A653697476 10_1186_s12936_021_03615_3 33549098 |
Genre | Journal Article |
GeographicLocations | Sierra Leone |
GeographicLocations_xml | – name: Sierra Leone |
GrantInformation_xml | – fundername: United States Center for Disease Control and Prevention grantid: U19GH001581 – fundername: ; grantid: U19GH001581 |
GroupedDBID | --- -A0 0R~ 29M 2WC 3V. 53G 5VS 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFGXO AFKRA AFNRJ AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBS ECGQY EMB EMK EMOBN ESX F5P FRP FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX ACMJI ALIPV CITATION EBLON PGMZT ABVAZ 7SS 7U9 7XB 8FK AZQEC C1K DWQXO F1W H94 H95 H97 K9. L.G M7N PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c563t-82e74fbe0ac8ec1f584b424cefa4e8bfee0aebdc13a77a6cbaba3bcc54948f073 |
IEDL.DBID | RPM |
ISSN | 1475-2875 |
IngestDate | Thu Sep 05 15:43:44 EDT 2024 Tue Sep 17 20:41:56 EDT 2024 Sat Aug 17 01:08:16 EDT 2024 Fri Sep 13 03:31:37 EDT 2024 Fri Feb 23 00:15:39 EST 2024 Fri Feb 02 04:30:24 EST 2024 Thu Sep 12 19:25:14 EDT 2024 Thu May 23 23:40:02 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Evaluation Household survey Malaria Coverage Infants Sierra Leone National scale-up IPTi |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-82e74fbe0ac8ec1f584b424cefa4e8bfee0aebdc13a77a6cbaba3bcc54948f073 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9748-9273 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866768/ |
PMID | 33549098 |
PQID | 2490912153 |
PQPubID | 42600 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_98b4740329f24f05ab59f230b661b41e pubmedcentral_primary_oai_pubmedcentral_nih_gov_7866768 proquest_miscellaneous_2487429771 proquest_journals_2490912153 gale_infotracmisc_A653697476 gale_infotracacademiconefile_A653697476 crossref_primary_10_1186_s12936_021_03615_3 pubmed_primary_33549098 |
PublicationCentury | 2000 |
PublicationDate | 2021-02-06 |
PublicationDateYYYYMMDD | 2021-02-06 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-06 day: 06 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Malaria journal |
PublicationTitleAlternate | Malar J |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | CV Plowe (3615_CR16) 1995; 52 R Kobbe (3615_CR5) 2007; 45 D Chandramohan (3615_CR3) 2005; 331 3615_CR1 3615_CR2 JM Ngondi (3615_CR15) 2017; 16 J Zolg (3615_CR18) 1989; 36 LR Feldstein (3615_CR36) 2020; 10 D Schellenberg (3615_CR9) 2001; 357 3615_CR27 3615_CR28 RM Chico (3615_CR22) 2015; 20 3615_CR25 NMC Programme (3615_CR11) 2016 O Aydemir (3615_CR23) 2018; 218 JG Kublin (3615_CR20) 2002; 185 3615_CR40 JJ Aponte (3615_CR39) 2009; 374 A Cowman (3615_CR17) 1988; 85 MF Jalloh (3615_CR37) 2020; 38 SA Omar (3615_CR21) 2001; 95 MP Grobusch (3615_CR4) 2007; 196 M Gysels (3615_CR30) 2009; 8 C Pell (3615_CR31) 2010; 9 P Wang (3615_CR19) 1997; 23 3615_CR38 JNK Rao (3615_CR26) 1987; 15 3615_CR14 Sierra Leone Ministry of Health and Sanitation (3615_CR34) 2016 JJ Massaga (3615_CR7) 2003; 361 3615_CR12 M Deutsch-Feldman (3615_CR24) 2019; 19 R Pool (3615_CR29) 2006; 11 3615_CR13 3615_CR35 3615_CR10 3615_CR32 3615_CR33 FP Mockenhaupt (3615_CR8) 2007; 51 E Macete (3615_CR6) 2006; 194 |
References_xml | – volume: 19 start-page: 872 year: 2019 ident: 3615_CR24 publication-title: BMC Infect Dis doi: 10.1186/s12879-019-4523-0 contributor: fullname: M Deutsch-Feldman – ident: 3615_CR14 – ident: 3615_CR12 – volume: 95 start-page: 315 year: 2001 ident: 3615_CR21 publication-title: Trans R Soc Trop Med Hyg doi: 10.1016/S0035-9203(01)90250-0 contributor: fullname: SA Omar – ident: 3615_CR10 – volume: 194 start-page: 276 year: 2006 ident: 3615_CR6 publication-title: J Infect Dis doi: 10.1086/505431 contributor: fullname: E Macete – volume: 8 start-page: 191 year: 2009 ident: 3615_CR30 publication-title: Malar J doi: 10.1186/1475-2875-8-191 contributor: fullname: M Gysels – volume: 85 start-page: 9109 year: 1988 ident: 3615_CR17 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.85.23.9109 contributor: fullname: A Cowman – ident: 3615_CR33 – ident: 3615_CR2 – volume: 218 start-page: 946 year: 2018 ident: 3615_CR23 publication-title: J Infect Dis doi: 10.1093/infdis/jiy223 contributor: fullname: O Aydemir – volume-title: National Community Health Worker Policy 2016–2020 year: 2016 ident: 3615_CR34 contributor: fullname: Sierra Leone Ministry of Health and Sanitation – volume: 38 start-page: 6103 year: 2020 ident: 3615_CR37 publication-title: Vaccine doi: 10.1016/j.vaccine.2020.07.031 contributor: fullname: MF Jalloh – ident: 3615_CR28 – volume: 36 start-page: 253 year: 1989 ident: 3615_CR18 publication-title: Mol Biochem Parasitol doi: 10.1016/0166-6851(89)90173-4 contributor: fullname: J Zolg – ident: 3615_CR25 doi: 10.1101/656561 – volume: 185 start-page: 380 year: 2002 ident: 3615_CR20 publication-title: J Infect Dis doi: 10.1086/338566 contributor: fullname: JG Kublin – volume: 15 start-page: 385 year: 1987 ident: 3615_CR26 publication-title: Ann Stat doi: 10.1214/aos/1176350273 contributor: fullname: JNK Rao – volume: 52 start-page: 565 year: 1995 ident: 3615_CR16 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.1995.52.565 contributor: fullname: CV Plowe – volume: 45 start-page: 16 year: 2007 ident: 3615_CR5 publication-title: Clin Infect Dis doi: 10.1086/518575 contributor: fullname: R Kobbe – volume: 16 start-page: 236 year: 2017 ident: 3615_CR15 publication-title: Malar J doi: 10.1186/s12936-017-1886-9 contributor: fullname: JM Ngondi – volume: 361 start-page: 1853 year: 2003 ident: 3615_CR7 publication-title: Lancet doi: 10.1016/S0140-6736(03)13504-0 contributor: fullname: JJ Massaga – volume: 23 start-page: 979 year: 1997 ident: 3615_CR19 publication-title: Mol Microbiol doi: 10.1046/j.1365-2958.1997.2821646.x contributor: fullname: P Wang – volume: 11 start-page: 1670 year: 2006 ident: 3615_CR29 publication-title: Mozambique Trop Med Int Health doi: 10.1111/j.1365-3156.2006.01725.x contributor: fullname: R Pool – ident: 3615_CR40 – ident: 3615_CR13 – volume: 374 start-page: 1533 year: 2009 ident: 3615_CR39 publication-title: Lancet doi: 10.1016/S0140-6736(09)61258-7 contributor: fullname: JJ Aponte – volume: 51 start-page: 3273 year: 2007 ident: 3615_CR8 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00513-07 contributor: fullname: FP Mockenhaupt – volume: 9 start-page: 369 year: 2010 ident: 3615_CR31 publication-title: Malar J doi: 10.1186/1475-2875-9-369 contributor: fullname: C Pell – ident: 3615_CR38 doi: 10.1002/14651858.CD011525.pub2 – ident: 3615_CR32 – volume: 196 start-page: 1595 year: 2007 ident: 3615_CR4 publication-title: J Infect Dis doi: 10.1086/522160 contributor: fullname: MP Grobusch – ident: 3615_CR1 – volume: 357 start-page: 1471 year: 2001 ident: 3615_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(00)04643-2 contributor: fullname: D Schellenberg – ident: 3615_CR27 – volume: 331 start-page: 727 year: 2005 ident: 3615_CR3 publication-title: BMJ doi: 10.1136/bmj.331.7519.727 contributor: fullname: D Chandramohan – volume-title: Statistics Sierra Leone, College of Medicine and Allied Health Services University of Sierra Leone year: 2016 ident: 3615_CR11 contributor: fullname: NMC Programme – ident: 3615_CR35 doi: 10.1016/S2214-109X(17)30152-3 – volume: 20 start-page: 1621 year: 2015 ident: 3615_CR22 publication-title: Trop Med Int Health doi: 10.1111/tmi.12595 contributor: fullname: RM Chico – volume: 10 start-page: 010420 year: 2020 ident: 3615_CR36 publication-title: J Glob Health doi: 10.7189/jogh.10.010420 contributor: fullname: LR Feldstein |
SSID | ssj0017872 |
Score | 2.3909433 |
Snippet | Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against malaria.... Abstract Background Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants... Background Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against... BACKGROUNDIntermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants against... Abstract Background Intermittent preventive treatment of malaria in infants (IPTi) with sulfadoxine-pyrimethamine (SP) is a proven strategy to protect infants... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 74 |
SubjectTerms | Alleles Antimalarial agents Antimalarials Care and treatment Caregivers Children Children & youth Childrens health Community Coverage Data collection Demographic aspects Disease control Dosage and administration Evaluation Health facilities Households Human diseases Immunization Infant health services Infants IPTi Malaria Maternal & child health Measles Medical personnel Methods Mutation Parasites Polls & surveys Prevention Public health Pyrimethamine Questionnaires Sierra Leone Stock assessment Sulfadoxine Surveying Testing Time series Vaccination Vaccines Vector-borne diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlp0IpbdKH26SoUGhLMbH1zjEtCemTQhPITUiyRPYQ77Lr7R_rH-yMZZs1PfQS2MNijY2sGc1D_vSJkDeBMYdEa2Xy0ZQiIgjAGzyPWII7FEq6gAv633-oiyvx5Vpe7xz1hZiwTA-cB-74xHihRcXZSWIiVdJ5Cf945SGweFHH3vvWciymhu8HYIZs3CJj1PEGoxqCbRE-BDG85LMw1LP1_-uTd4LSHDC5E4HOH5GHQ-pIT3OXH5N7sd0nD_K6G83biQ7In7OJvpsuE83bHGnma6brHjEPvo26tqEB0ZvgTlAOWSNwaz9k0B1dDbROvyOdcOgodOugDF44EIZfQgANfff55-XiPV756m49tDVIxLsIHe2WNJOy0nG9kW7AHmK5XaH4LwjHa0e_xWUbn5Cr87PLTxflcDBDGaTiXWlY1AKUW7lgYqgTJDFeMBFiciIanyK0RN-EmjutnQreecd9CBK5aBI4ladkr4XHPydUyxSaBFlag0R-PhgGd2HRybWvG64L8mHUk11l_g3b1y1G2axVC1q1vVYtL8hHVOUkidzZ_QWwKDtYlP2fRRXkLRqCxUECbQc3bFSADiNXlj1Vkissw1RBDmeSMDPDvHk0JTt4ho2FchdSNEi0oLOvp2a8E9FubVxuUcZoyBO0rgvyLFve9EqcS3yCKYie2eTsnect7eKm5w3XBgHN5sVdDNJLcp_104mVlToke916G48gPev8q34m_gVX5TmC priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZpcimU0nedpkWFQluKWVuSJeVUkrJh-wqhTSA3IclSu4fYm11v_1j_YGf8akyh4IOxxsb2jGZG0jefCHnlGbNItJZGF3QqAoIAnMb9iAtwh0IW1uOE_tdTubgQny6Lyx2yGGphEFY5-MTWUZe1xznyGQwTILRBgOIz63AWwDez96vrFPePwnXWfjONW2SP5QIXbPeO56dn38YVBTBMNhTNaDnbYJxD-C0CiiCqp3wSmFr-_n-99I0wNYVQ3ohJJ_fI3T6ZpEed9u-TnVA9IHe6mTjaFRg9JL_nI6E3rSPtCh9px-BM1y2GHrwdtVVJPeI5wcGgHPJIYLE_5NQNXfVET78CHZHpKHRlYWC8tCAMR0RIDX3z8ex8-RavfLZXDtpKpOZd-oY2Ne1oWukwA0k3YCEh3a5Q_DsE6LWlX0JdhUfk4mR-_mGR9ls1pL6QvEk1C0qAujPrdfB5hLTGCSZ8iFYE7WKAluBKn3OrlJXeWWe5875AdpoIbuYx2a3g8U8JVUX0ZYS8rURqP-c1g7twGMqVy0uuEvJu0JNZdYwcph3JaGk6rRrQqmm1anhCjlGVoySyabcX6vUP03dOc6idUCLj7DAyEbPCugLOeOYgeXEiDwl5jYZg8Ceh5dm-dAFeGNmzzJEsuMSBmUzIwUQS-qqfNg-mZHpfsTF_LTshL8dmvBPxb1WotyijFWQOSuUJedJZ3vhJnBf4BJ0QNbHJyTdPW6rlz5ZJXGmEOOv9_7_WM3KbtR2FpZk8ILvNehueQyrWuBd9L_sDqTc3JA priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals (Open Access) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Ni9UwEA_rehFE_La6SgTBg1Rfm889iKyyy6KuF32wt5CkyfrAbZ99faL_k3-kM-mHW9yD0ENppqHJzGRm0plfCHnmy9Ii0FoeXdA5D5gE4DSeRyxgOeRSWI8b-ief5PGSvz8VpztkPO5omMDNpaEdnie1bL-9_Pn91xtQ-NdJ4bV8tUGbham0mBwEFjpnV8jVkjOOEn_C__5VAOFMfz-5EjlECmIsorm0j5mhSnj-_67aF8zWPKXygo06ukluDM4lPeil4RbZCfVtcr3fmaN9wdEd8vtwAvimTaR9ISTtEZ1pm3LqYfWjtq6ox_xOWHCQDnElsPgffOyOrgfgpx-BTpnqSHRuYTZXFojhiphig7cf7LmDhxVi9K58R7uG9nitdNyKpBsQlZBv10j-GSx1a-nH0NThLlkeHX55d5wPZzbkXkjW5boMigPfF9br4IsI_o3jJfchWh60iwFagqt8waxSVnpnnWXOe4EwNRHWm3tkt4buHxCqRPRVBAeuQow_53UJb2E8ypQrKqYy8mJkkFn30BwmhTRamp6dBthpEjsNy8hb5OFEibDa6UHTnplBS82-dlzxBSv3Y8njQlgn4I4tHHgxjhchI89RAgxOErDZ26GGAT4YYbTMgRRMYoQmM7I3owSl9fPmUYbMKPMGImHw3sAHg499OjXjm5gIV4dmizRagQuhVJGR-73ITUNiTGAPOiNqJoyzMc9b6tXXBCmuNOY664f_Pb5H5FqZlKXMF3KP7HbtNjwG96xzT5LO_QFm3zmD priority: 102 providerName: Scholars Portal |
Title | Evaluation of health system readiness and coverage of intermittent preventive treatment of malaria in infants (IPTi) in Kambia district to inform national scale-up in Sierra Leone |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33549098 https://www.proquest.com/docview/2490912153/abstract/ https://search.proquest.com/docview/2487429771 https://pubmed.ncbi.nlm.nih.gov/PMC7866768 https://doaj.org/article/98b4740329f24f05ab59f230b661b41e |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZt9zIYo7vWWxc0GGxjuLEl2VIe25DSXVLC1kLehCRLW2BxQuL0j-0P7hxfQs3eBsEE68jIOVcpnz4R8s4xZpBoLQ7Wq1h4BAFYhecRZxAORZ4Zhwv60-v86lZ8mWfzA5J1e2Fq0L6zi7Py9_KsXPyqsZXrpRt2OLHhbDqWCpGZanhIDiXn3RS9_esALJB1u2NUPtxiQkOcLSKHIH3HeHIO5zAtSkaql4xqzv5_I_O91NSHTd7LQ5fH5HFbQNLzZqBPyIEvn5JHzeobbTYVPSN_JnsSb7oKtNnsSBvWZrqpcfMQ4agpC-oQwwlBBeWQOwI3-EMdXdF1S-505-kejY5CSwOT4YUBYfgEhNHQD59nN4uPeOerWVpoK5COd-EqWq1oQ81Ku1VHugWr8PFujeI_IClvDP3mV6V_Tm4vJzfjq7g9niF2Wc6rWDEvBag4MU55lwYoZaxgwvlghFc2eGjxtnApN1Ka3FljDbfOZchIEyC0vCBHJTz-hFCZBVcEqNUKpPOzTjHohVNPLm1acBmRT52e9Lph4dD17EXlulGwBgXrWsGaR-QCVbmXRAbt-sZq81O3dqRHygopEs5GgYmQZMZm8I0nFgoWK1IfkfdoCBp_JNC2M-12BRgwMmbp8zzjOU7G8oic9iTBP12_uTMl3caHrWZofkjsAYN9u2_Gnoh5K_1qhzJKQrUgZRqRl43l7V-pM-CIyJ5N9t653wLOVLOHt87z6r97viYPWe1OLE7yU3JUbXb-DVRmlR2AP84lXNU4HZAHF5Pr2fdBvcoB16lQg9pT_wJUDEBP |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,12250,21416,24346,27957,27958,31754,31755,33301,33302,33779,33780,43345,43614,43840,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB60PigU8dpGq44gqEhokrn2Saq0bO22CG5h34aZyYzuQ5N1N-sf8w96TpKNDYKQh5BzEpI9Z85l9ptvCHnji8Ii0VoaXdApDwgCcBr3IxYQDrkU1uOE_sWlnFzxL3Mx7yfc1j2schsT20Bd1h7nyA-hTYDUBgmKfVz-THHXKPx3td9C4za5wxnjCOlT86HhysEZi-1CGS0P15jbEHKLICLI5CkbJaOWs__fyHwjNY1hkzfy0OkDcr8vIOlxZ_GH5FaoHpHdbvaNdouKHpPfJwOJN60j7RY70o61ma5a3DxEOGqrknrEcEJQQT3kjsAF_lBHN3TZkzv9CnRAo6PStYVmeGFBGY6IMBr67uzrbPEer5zbaweyEul4F76hTU07ala6nXWka_CKkG6WqP4NkvLK0mmoq_CEXJ2ezD5P0n57htQLyZpUF0FxMHFmvQ4-j1DKOF5wH6LlQbsYQBJc6XNmlbLSO-ssc94LZKSJEFqekp0KHr9PqBLRlxFqtRLp_JzXBdyFrSdTLi-ZSsiHrZ3MsmPhMG33oqXprGrAqqa1qmEJ-YSmHDSRQbu9UK--m35AmiPtuOIZK45iwWMmrBNwxjIHBYvjeUjIW3QEgz8SWNvbfrkCvDAyZpljKZjEZkwm5GCkCePTj8VbVzJ9fFibv96ckNeDGO9EzFsV6g3qaAXVglJ5QvY6zxs-iTGBT9AJUSOfHH3zWFItfrTs4UojrFk_-_9rvSJ3J7OLqZmeXZ4_J_eKdtAUaSYPyE6z2oQXUIo17mU73v4Az5o08Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bixMxFA66ggji_TK6agRBRaYzTTKT9HFdt-y6FwruwuJLSDKJFu20tFMf_Fv-Qc-ZS-no20IfhslJmXS-nEv65QshbxxjBoXW4mC9ioVHEoBVeB5xBu5Q5JlxuKB_epYfXojPl9nl1lFfNWnf2emg_DkblNPvNbdyMXNJxxNLJqf7UiEzUyWLIiTXyQ2Ys2zUFertHwiAQ9btkVF5ssKwhmxb5A9BEI_x_BzOoThKR6oXkmrl_v_981aA6pMnt6LR-C752o2jIaH8GKwrO3C__5F4vNJA75E7bY5K9xqT--SaLx-Q280CH232LT0kfw42OuF0Hmizn5I2wtB0WVPzwYlSUxbUIU0U_BbaoTwFaghAql7RRasf9cvTDeEdjWYG6u2pAWP4BGTq0HdHk_Ppe7xzbGYW2gpU_J26ilZz2qi_0m5hk64AeD5eL9D8C8T9paEnfl76R-RifHC-fxi3J0DELst5FSvmpQAUpcYp74YBsiUrmHA-GOGVDR5avC3ckBspTe6ssYZb5zIUvQngvR6TnRK-_imhMguuCJAOFqgYaJ1i0AurWy7tsOAyIh86EOhFI_Sh6wJJ5bpBjwb06Bo9mkfkI-JkY4ki3fWN-fKbbt-gHikrpEg5GwUmQpoZm8EVTy3kRFYMfUTeIso0_kgAJWfaHRHwwCjKpffyjOdY7-UR2e1Zggtw_eYOp7p1QSvNENuoHQIP-3rTjD2RVlf6-RptlISERMphRJ40sN4MqZsdEZE9wPfG3G8BGNcC5S1sn1255ytyc_JprE-Ozo6fk1usnrYsTvNdslMt1_4F5IGVfVnP-L_ajV-6 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+health+system+readiness+and+coverage+of+intermittent+preventive+treatment+of+malaria+in+infants+in+Kambia+district+to+inform+national+scale-up+in+Sierra+Leone&rft.jtitle=Malaria+journal&rft.au=Lahuerta%2C+Maria&rft.au=Sutton%2C+Roberta&rft.au=Mansaray%2C+Anthony&rft.au=Eleeza%2C+Oliver&rft.date=2021-02-06&rft.pub=BioMed+Central+Ltd&rft.issn=1475-2875&rft.eissn=1475-2875&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12936-021-03615-3&rft.externalDocID=A653697476 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2875&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2875&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2875&client=summon |